This work aimed to improve upon the solubility and delivery of the potent N-alkylisatin (N-AI) cytotoxin to uPA/uPAR positive breast cancer cells, through the conjugation of PAI-2 to the surface of PEGylated N-AI-loaded liposomes. Here, PLAU is linked to breast cancer.